Abstract
Therapy strategy toward epidermal growth factor receptor (EGFR) inhibition in cervical cancer has been ongoing. EGFR promoter methylation status and EGFR tyrosine kinase inhibitor-sensitive mutations in cervical cancer may be significant for clinical outcome prediction using anti-EGFR treatment. In this study, EGFR tyrosine kinase inhibitor-sensitive mutations, EGFR exons 18, 19, and 21 mutations, were detected by sequencing in a total of 293 Chinese cervical squamous cell carcinoma tissue samples. EGFR promoter methylation status was detected by an EGFR asymmetric PCR and hybridization-fluorescence polarization assay and sequencing in 293 Chinese cervical squamous cell carcinoma tissue samples. High-risk human papillomavirus (HPV) genotypes in 293 Chinese cervical squamous cell carcinoma tissue samples were detected by an asymmetric GP5+/6+ PCR and hybridization-fluorescence polarization assay. No EGFR exons 18, 19, and 21 mutations were detected, EGFR promoter methylation status was identified in 98 samples, and HPV 16 infection was the first frequent HPV genotype. The methylated EGFR promoter was identified most frequently in cervical squamous cell carcinoma samples with HPV 16 infection (53.4%). Statistical significant diff...Continue Reading
References
Dec 21, 1988·Journal of the National Cancer Institute·E Aboud-PirakM Sela
Feb 1, 1996·Gynecologic Oncology·J W KimJ W Lee
Mar 1, 1997·Journal of Clinical Microbiology·M V JacobsJ M Walboomers
Oct 13, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R I NicholsonM E Harper
Dec 26, 2001·Oncogene·D DiMaio, D Mattoon
May 15, 2004·International Journal of Radiation Oncology, Biology, Physics·Roy S Herbst
Mar 16, 2007·Gynecologic Oncology·Sokbom KangSeung Myung Dong
Mar 21, 2007·Cancer Biology & Therapy·Alberto J MonteroJean-Pierre J Issa
Jun 2, 2007·Gynecologic Oncology·Stefania BelloneAlessandro D Santin
Nov 6, 2007·Gynecologic Oncology·A GoncalvesP Viens
May 23, 2008·BMC Cancer·Hongdo DoAlexander Dobrovic
Jan 16, 2009·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Zhang JuLiu Yonglan
Jul 4, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Russell J SchilderRobert Mannel
Nov 19, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maartje G NoordhuisAte G J van der Zee
Feb 25, 2010·Archives of Gynecology and Obstetrics·Linda HertleinKlaus Friese
Sep 23, 2010·American Journal of Clinical Oncology·José Pérez-RegaderaEduardo Lanzós
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Feb 18, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T SoonthornthumC Verschraegen
Jun 21, 2011·Gynecologic Oncology·Alessandro D SantinCecelia H Boardman
Jul 7, 2011·British Journal of Cancer·K IidaK Miyazaki
Oct 11, 2011·Virology·Craig D WoodworthSumona Mondal
Jun 26, 2012·Cancer Treatment Reviews·Giannis MountziosChristos A Papadimitriou
May 1, 2013·Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B·Wei ZhangJu Zhang
Feb 5, 2014·Journal of Cancer·Patrizia ViciAldo Venuti
Citations
Jul 3, 2015·Oncology Reports·Xuesong SongWenjie Zhang
Feb 18, 2016·BioMed Research International·Bhornprom YoysungnoenSuthiluk Patumraj
Jul 29, 2016·PloS One·Liangsheng GuoMin Hu
Sep 12, 2020·The International Journal of Biological Markers·Hongwen YangLihua Long
Aug 12, 2016·International Journal of Oncology·Zhiqiang PengJunfang Zheng
Jun 1, 2018·International Journal of Genomics·Chunyang FengTianmin Xu
Nov 10, 2020·Current Opinion in Pharmacology·Dominik DiefenbachThomas Efferth